Janux Therapeutics, Inc. - JANX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 8.9% | 5,350,453 | View |
| Feb 06, 2026 | SCHEDULE 13G | Prosight Management, LP | 5.2% | 3,150,970 | View |
| Feb 06, 2026 | SCHEDULE 13G | Prosight Fund, LP | 0.2% | 148,416 | View |
| Feb 06, 2026 | SCHEDULE 13G | Prosight Plus Fund, LP | 1.1% | 685,220 | View |
| Feb 06, 2026 | SCHEDULE 13G | Prosight Partners, LLC | 5.2% | 3,150,970 | View |
| Feb 06, 2026 | SCHEDULE 13G | W. Lawrence Hawkins | 5.3% | 3,157,220 | View |
| Jan 08, 2026 | SCHEDULE 13G/A | FMR LLC | 5.8% | 3,512,384 | View |
| Jan 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 5.8% | 3,512,384 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 10.0% | 6,033,949 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.